|
Cardenas-Freytag, L; Cheng, E; Mirza, A (1999) New approaches to mucosal immunization. Adv Exp Med Biol 473:319-37
|
|
Cardenas-Freytag, L; Cheng, E; Mayeux, P et al. (1999) Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis. Infect Immun 67:826-33
|
|
Wang, Y; Li, S P; Moser, S A et al. (1998) Cytokine involvement in immunomodulatory activity affected by Candida albicans mannan. Infect Immun 66:1384-91
|
|
Li, S P; Lee, S I; Domer, J E (1998) Alterations in frequency of interleukin-2 (IL-2)-, gamma interferon-, or IL-4-secreting splenocytes induced by Candida albicans mannan and/or monophosphoryl lipid A. Infect Immun 66:1392-9
|
|
Domer, J E; Asherson, G L; Li, S (1996) Treatment of Candida albicans mannan-specific downregulatory cell populations with divergent concentrations of monophosphoryl lipid A and intact lipopolysaccharide in vitro abrogates their effect on delayed hypersensitivity. Cell Immunol 167:8-17
|
|
Li, S P; Lee, S I; Wang, Y et al. (1996) Candida albicans mannan-specific, delayed hypersensitivity down-regulatory CD8+ cells are genetically restricted effectors and their production requires CD4 and I-A expression. Int Arch Allergy Immunol 109:334-43
|
|
Mayeux, P; Dupepe, L; Dunn, K et al. (1995) Massive fungal contamination in animal care facilities traced to bedding supply. Appl Environ Microbiol 61:2297-301
|
|
Stevens, D A; Domer, J E; Ashman, R B et al. (1994) Immunomodulation in mycoses. J Med Vet Mycol 32 Suppl 1:253-65
|
|
Garner, R E; Domer, J E (1994) Lack of effect of Candida albicans mannan on development of protective immune responses in experimental murine candidiasis. Infect Immun 62:738-41
|
|
Domer, J E; Human, L G; Andersen, G B et al. (1993) Abrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A. Infect Immun 61:2122-30
|
Showing the most recent 10 out of 18 publications
